Joanna Yao, general manager of Taiwan & Hong Kong at Baxter, documents the company’s commitment to bring the most innovative renal diseases solutions and expertise to Taiwanese patients and physicians and the strategic role played by the affiliate in nurturing an innovation-centered relationship that originates from Taiwan’s world-class healthcare system and benefits the Baxter ecosystem globally.
We saw that Taiwan has one of the highest end-stage renal disease rates in the world at nearly 12 percent. How can this high prevalence be explained?
"Overall, chronic kidney disease (CKD) is becoming a global health concern with one in 10 people worldwide having some degree of the disease"
